United Therapeutics (UTHR) Payables (2016 - 2025)
Historic Payables for United Therapeutics (UTHR) over the last 17 years, with Q3 2025 value amounting to $468.0 million.
- United Therapeutics' Payables rose 2860.68% to $468.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $468.0 million, marking a year-over-year increase of 2860.68%. This contributed to the annual value of $344.5 million for FY2024, which is 1560.4% up from last year.
- According to the latest figures from Q3 2025, United Therapeutics' Payables is $468.0 million, which was up 2860.68% from $432.0 million recorded in Q2 2025.
- United Therapeutics' Payables' 5-year high stood at $468.0 million during Q3 2025, with a 5-year trough of $165.0 million in Q1 2021.
- In the last 5 years, United Therapeutics' Payables had a median value of $292.0 million in 2023 and averaged $280.1 million.
- Its Payables has fluctuated over the past 5 years, first crashed by 663.1% in 2021, then soared by 5147.66% in 2023.
- Over the past 5 years, United Therapeutics' Payables (Quarter) stood at $174.6 million in 2021, then skyrocketed by 31.67% to $229.9 million in 2022, then increased by 29.62% to $298.0 million in 2023, then grew by 15.6% to $344.5 million in 2024, then skyrocketed by 35.85% to $468.0 million in 2025.
- Its last three reported values are $468.0 million in Q3 2025, $432.0 million for Q2 2025, and $367.0 million during Q1 2025.